www.bostonglobe.com

www.bostonglobe.com
Share

www.bostonglobe.com

 •  September 24

Attorney General Maura Healey, along with attorneys general from 38 other states, is seeking information from five opioid manufacturers and three distributors as they expand an investigation into the origins of the addiction crisis that has claimed thousands of lives. At an announcement Tuesday in Boston, Healey said the attorneys general are...

www.bostonglobe.com

 •  August 5

nly three types of drug-resistant bacteria make the Center for Disease Control and Prevention’s list of “urgent” threats. One of them is gonorrhea. That particular sexually transmitted infection is the target of a new drug being developed by Entasis, an antibiotics-focused spin-off from pharma giant AstraZeneca. But they’re getting help: their...

www.bostonglobe.com

 •  July 27

Repeated scandals helped create the Food and Drug Administration we know today: a thriving agency that effectively protects consumers and patients from unsafe food and drugs. However, Congress is overdue in passing legislation necessary to keep the FDA running, with one senator threatening further delay to force adoption of a policy that limits the...

www.bostonglobe.com

 •  July 10

An experimental hemophilia drug developed by Alnylam Pharmaceuticals continues to stanch bleeding in patients followed for almost one year in an ongoing, mid-stage clinical trial, the company reported Monday. The promising results could intensify an already heated competition to develop novel treatments for the inherited bleeding disorder. The...

www.bostonglobe.com

 •  June 9

What is it? A pigeon as a drug mule Innovator: Iraqi drug smugglers What were they thinking? Kuwait likes to party — or at least some people there do. But scoring party drugs can be a challenge. Enter the party fowl. Kuwaiti newspaper Al Rai recently reported that drug smugglers in neighboring Iraq recently affixed a tiny backpack to a pigeon and...

www.bostonglobe.com

 •  May 9

French pharmaceutical giant Sanofi SA, which became a major player in Boston area biotech when it bought Genzyme Corp. in 2011, unveiled a drug pricing policy Tuesday that includes limiting annual US increases to a federal government health spending gauge. Sanofi, which sells more than 70 medicines and vaccines in the United States, is the latest...

www.bostonglobe.com

 •  April 25

Biogen Inc. released data Monday from a late-stage clinical trial showing its recently approved treatment for spinal muscular atrophy significantly improved motor function in older children with later-onset types of the neuromuscular disease. The findings, to be presented at the American Academy of Neurology annual meeting in Boston, are likely to...

www.bostonglobe.com

 •  April 10

For biotechs, waiting for new drugs to be approved is not as hard as it used to be. Since late last year, federal regulators have acted months earlier than expected to OK a bumper crop of new drugs from Massachusetts companies. The speedy decisions are welcomed by businesses that have made massive investments in developing experimental medicines...

www.bostonglobe.com

 •  March 28

Early approval of an innovative new drug to treat ovarian cancer Monday provided new hope to tens of thousands of American women suffering from recurrent forms of the disease — and gave a huge boost to Tesaro Inc., the Waltham biotech that developed the medicine. The drug, which will be launched in the United States next month under the brand name...

www.bostonglobe.com

 •  February 27

The pharmaceutical industry in the United States is impressive. It is producing new drugs that can radically improve or even save people’s lives. But as these companies produce amazing advances, why does it appear that some are taking advantage of the very people the drugs are meant to help? Without painting the industry too broadly, if we are...